Covid 19

Biography

Tony is a clinician/scientist with a career spanning over 40 years. During this time, he has made a substantial contribution to our understanding of how the immune system is regulated in health and disease.

In 2007, Tony took sabbatical leave to spend time as a visiting fellow with Sir Gregory Winter FRS at Cambridge University, England. Now, back at Garvan with the B Cell Biology group, he is continuing his work on the regulation of the immune system with a focus on the mechanisms that normally prevent unwanted responses (autoimmune and allergic); the ultimate goal being to devise novel ways of treating patients with these conditions.

Tony is a Non-Executive Director of BioTech Capital Limited and Apollo Life Sciences, and a member of the Scientific Advisory Board of Human Genetic Signatures.

Research Interests;

Regulation of immune responses in health and disease

Clinical trials of immunomodulatory agents in cancer, multiple sclerosis and deep vein thrombosis.https://www.garvan.org.au/